Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety、Immunogenicity”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01867463
What this trial is testing

Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 230
Testing effectiveness (Phase 2)Study completedNCT02190721
What this trial is testing

Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

Who this might be right for
Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc. 50
Early research (Phase 1)Study completedNCT02114333
What this trial is testing

Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds

Who this might be right for
ShinglesHerpes Zoster
University of Colorado, Denver 160
Large-scale testing (Phase 3)Study completedNCT05567471
What this trial is testing

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

Who this might be right for
COVID-19 Respiratory Infection
Bharat Biotech International Limited 875
Testing effectiveness (Phase 2)WithdrawnNCT05016934
What this trial is testing

Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized

Who this might be right for
Covid19
Hospital do Coracao
Testing effectiveness (Phase 2)Study completedNCT00802464
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Who this might be right for
Herpes Zoster
GlaxoSmithKline 410
Early research (Phase 1)Study completedNCT04523571
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects

Who this might be right for
SARS-CoV-2
BioNTech SE 144
Early research (Phase 1)Study completedNCT00464334
What this trial is testing

V950 in People With Alzheimer Disease (V950-001 AM7)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 86
Large-scale testing (Phase 3)Study completedNCT01755364
What this trial is testing

A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old

Who this might be right for
Influenza
Adimmune Corporation 122
Testing effectiveness (Phase 2)Looking for participantsNCT06702449
What this trial is testing

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Who this might be right for
Urinary Tract Infections
GlaxoSmithKline 448
Testing effectiveness (Phase 2)Study completedNCT01152814
What this trial is testing

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011

Who this might be right for
Seasonal Influenza
Novartis Vaccines 64
Early research (Phase 1)Study completedNCT01073306
What this trial is testing

Safety and Immune Response to an Investigational Dengue Type 2 Vaccine

Who this might be right for
Dengue Virus
National Institute of Allergy and Infectious Diseases (NIAID) 18
Large-scale testing (Phase 3)Study completedNCT00395174
What this trial is testing

Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults

Who this might be right for
Influenza
Protein Sciences Corporation 870
Large-scale testing (Phase 3)Study completedNCT03525210
What this trial is testing

Study of Safety, Tolerability and Immunogenicity of Gardasil®9 in Immunocompromised Patients

Who this might be right for
Human Papilloma VirusHivOrgan Transplants
Universitaire Ziekenhuizen KU Leuven 271
Early research (Phase 1)WithdrawnNCT01399424
What this trial is testing

Shigella Sonnei OSPC-rDT Conjugate Vaccine

Who this might be right for
Shigellosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Early research (Phase 1)Study completedNCT00057525
What this trial is testing

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

Who this might be right for
Anthrax
DynPort Vaccine Company LLC, A GDIT Company 70
Early research (Phase 1)Ended earlyNCT04960397
What this trial is testing

Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

Who this might be right for
H3N2 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 140
Early research (Phase 1)Study completedNCT05407779
What this trial is testing

Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of Single Escalating Doses of BCD-180 in Healthy Volunteers

Who this might be right for
Healthy
Biocad 39
Testing effectiveness (Phase 2)Temporarily pausedNCT05150496
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 640
Testing effectiveness (Phase 2)Ended earlyNCT04445389
What this trial is testing

Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

Who this might be right for
SARS-CoV-2
Genexine, Inc. 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation